Search

everythinglearnresearchcommunity

for

Search:↓

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

New genes found linked to balding, may help develop future treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

FLRG and follistatin have different roles in wound healing.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Trichoscopy is a useful tool for diagnosing hair disorders without pulling out hair.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride effectively treats hair loss in transgender men with few side effects.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Men with testicular cancer were less likely to experience baldness and severe acne.

Steroidogenic isoenzymes may help improve treatments for common hair loss.